Improved outcome for children with acute lymphoblastic leukemia by prolonging therapy for ikzf1 deletion and decreasing therapy for etv6::runx1, down syndrome or prednisone poor response
PEDIATRIC BLOOD & CANCER(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要